Clinical Trial Update: A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes a single-arm Phase II study evaluating the combination of entinostat and oral paclitaxel for hormone receptor-positive, HER2-ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Entinostat (entinostat)
• Oral Paclitaxel (paclitaxel)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING